Bayard L. Powell, MD | Authors

Articles

CPI-613 in Combination With High Dose ARA-C and Mitoxantrone

January 06, 2015

Bayard L. Powell, MD, discusses a phase I study that looked at CPI-613 in combination with high dose ARA-C and mitoxantrone for the treatment of patents with relapsed/refractory acute myeloid leukemia (AML).